Projects per year
Professor John Zalcberg was the Director, Division of Cancer Medicine, at the Peter MacCallum Cancer Centre in Melbourne, Australia for 17 years prior to recently taking up the position of Professor of Cancer Research in the School of Public Health and Preventive Medicine at Monash University.
After earning a Bachelor of Medicine and Bachelor of Surgery from the University of Melbourne and a PhD in cancer immunology, he served as Director of Medical Oncology at the Heidelberg Repatriation Hospital and as Director of Cancer Services at the Austin and Repatriation Medical Centre.
A founder of the Lorne Cancer Conference and the Australasian Gastrointestinal Trials Group (AGITG), he is immediate past Chair of the Board of AGITG after serving in this role for over 15 years and a past Board Member of Cancer Trials Australia. He is the current Co-Chair of the Cancer Drugs Alliance and Interim Chair of the Australian Clinical Trials Alliance.
A past Board Member of the NSW Cancer Institute, past President of the Clinical Oncological Society of Australia, and a past Member of the Consultative Council of the Victorian Cancer Agency, he has received a Medal of the Order of Australia Award (OAM) and the 2011 Cancer Achievement Award from the Medical Oncology Group of Australia.
Professor Zalcberg's clinical research interests include gastrointestinal cancer and health care outcomes. He has published more than 230 articles in peer-reviewed journals. He was a Principal Investigator for the EORTC advanced GIST trial in Australia and continues an active involvement in trials in this disease as well as other GI cancers. He continues an active clinical practice in GI cancer.
2014 - Professor of Cancer Research
2012 - Interim Chair, Australian Clinical Trials Alliance
2013 - NED, Board of Australian Red Cross Blood Service
2013 - Co-Chair, Cancer Drugs Alliance
2009 - Member, External Advisory Board of South London Integrated Cancer Centre
1993 - 2014 Australasian Gastrointestinal Trials Group
1995 - 2008 Progen Pharmaceuticals
2003 - 2014 Cancer Trials Australia
2003 - 2005 NSW Cancer Institute
2012 - Cancer Drugs Alliance
2013 - Australian Red Cross Blood Service
2013 - Australian Clinical Trials Alliance
1/07/19 → 30/09/19
Real-time patient-reported outcomes measures (PROMs) in clinical practice – a novel approach to improving quality of care for patients with upper gastrointestinal cancer
15/02/19 → 14/02/23
8/01/19 → 8/07/20
ICAN: Immunoglobulin use and outcomes in Chronic lymphocytic leukaemia And Non-Hodgkin lymphoma – the ICAN study
19/12/18 → 31/12/21
Research Output per year
Research output: Book/Report › Other Report › Other › peer-review
Research output: Contribution to journal › Article › Other › peer-review
Research output: Contribution to journal › Article › Research › peer-review
Research output: Contribution to journal › Letter › Other › peer-review
Research output: Contribution to conference › Poster › Other › peer-review